Votrient (pazopanib) now available for the treatment of advanced renal cell ... - Pharmacy Europe PDF Print
Pharmacy EuropeGlaxoSmithKline (GSK) announced today that Votrient (pazopanib) is now available for the first-line treatment of patients with advanced renal cell carcinoma ...Votrient®? (pazopanib) now available for the treatment of advanced renal cell

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.